Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease

• Olivier Hermine ,

  Roles Conceptualization, Writing – review & editing

  * E-mail: ohermine@gmail.com

  Affiliations Imagine Institute, INSERM UMR 1163, University of Paris, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implication, Hôpital Necker, Paris, France, Department of Hematology, Necker Hospital, Assistance Publique Hôpitaux de Paris, Paris, France

  ⨯
• Laurent Gros,

  Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing

  Affiliation AB Science, Paris, France

  ⨯
• Truong-An Tran,

  Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing

  Affiliation AB Science, Paris, France

  ⨯
• Lamya Loussaief,

  Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing

  Affiliation AB Science, Paris, France

  ⨯
• Kathleen Flosseau,

  Roles Conceptualization, Data curation, Writing – review & editing

  Affiliation AB Science, Paris, France

  ⨯
• Alain Moussy,

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation AB Science, Paris, France

  ⨯
• Colin D. Mansfield,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation AB Science, Paris, France

  https://orcid.org/0000-0001-9175-5051

  ⨯
• Patrick Vermersch

  Roles Conceptualization, Writing – review & editing

  Affiliation Univ. Lille, UMR Inserm U1172, CHU Lille, FHU Precise, Lille, France

  ⨯